BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

413 related articles for article (PubMed ID: 34253104)

  • 21. Silencing lncRNA DUXAP8 inhibits lung adenocarcinoma progression by targeting miR-26b-5p.
    Liu Y; Zhang G; Chen H; Wang H
    Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33269379
    [TBL] [Abstract][Full Text] [Related]  

  • 22. lncRNA ZFPM2-AS1 promotes proliferation via miR-18b-5p/VMA21 axis in lung adenocarcinoma.
    Xue M; Tao W; Yu S; Yan Z; Peng Q; Jiang F; Gao X
    J Cell Biochem; 2020 Jan; 121(1):313-321. PubMed ID: 31297866
    [TBL] [Abstract][Full Text] [Related]  

  • 23. LncRNA LOXL1-AS1 regulates the tumorigenesis and development of lung adenocarcinoma through sponging miR-423-5p and targeting MYBL2.
    Li W; Zhang B; Jia Y; Shi H; Wang H; Guo Q; Li H
    Cancer Med; 2020 Jan; 9(2):689-699. PubMed ID: 31758653
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel long non-coding RNA LINC02323 promotes epithelial-mesenchymal transition and metastasis via sponging miR-1343-3p in lung adenocarcinoma.
    Zhang X; Du L; Han J; Li X; Wang H; Zheng G; Wang Y; Yang Y; Hu Y; Wang C
    Thorac Cancer; 2020 Sep; 11(9):2506-2516. PubMed ID: 32643848
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Potentiated lung adenocarcinoma (LUAD) cell growth, migration and invasion by lncRNA DARS-AS1 via miR-188-5p/ KLF12 axis.
    Liu Y; Liang L; Ji L; Zhang F; Chen D; Duan S; Shen H; Liang Y; Chen Y
    Aging (Albany NY); 2021 Oct; 13(19):23376-23392. PubMed ID: 34644678
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Circle RNA FOXP1 promotes cell proliferation in lung cancer by regulating miR-185-5p/Wnt1 signaling pathway.
    Li O; Kang J; Zhang JJ; Wang J; Hu LW; Li L; Sun YY; Bai Y; Wei QQ; Yan YP; Yi X
    Eur Rev Med Pharmacol Sci; 2020 Jun; 24(12):6767-6778. PubMed ID: 32633368
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [LncRNA DRAIC regulates the proliferation, apoptosis, migration and invasion of lung adenocarcinoma cells by targeting let-7i-5p].
    Liu BL; Cui YS; Tian YP; Zhu YZ; Hong ZQ; Zhang XM; Sun GG
    Zhonghua Zhong Liu Za Zhi; 2023 Jun; 45(6):471-481. PubMed ID: 37355465
    [No Abstract]   [Full Text] [Related]  

  • 28. Long noncoding RNA FBXL19-AS1 induces tumor growth and metastasis by sponging miR-203a-3p in lung adenocarcinoma.
    Wang L; Zhang X; Liu Y; Xu S
    J Cell Physiol; 2020 Apr; 235(4):3612-3625. PubMed ID: 31566718
    [TBL] [Abstract][Full Text] [Related]  

  • 29. LncRNA surfactant associated 1 activates large tumor suppressor kinase 1/Yes-associated protein pathway via modulating hypoxic exosome-delivered miR-4766-5p to inhibit lung adenocarcinoma metastasis.
    Zhang W; Bai M; Liu K; Tan J; Ma J; Zhao J; Hou P
    Int J Biochem Cell Biol; 2022 Dec; 153():106317. PubMed ID: 36283586
    [TBL] [Abstract][Full Text] [Related]  

  • 30. STAT1-induced upregulation of LINC00467 promotes the proliferation migration of lung adenocarcinoma cells by epigenetically silencing DKK1 to activate Wnt/β-catenin signaling pathway.
    Yang J; Liu Y; Mai X; Lu S; Jin L; Tai X
    Biochem Biophys Res Commun; 2019 Jun; 514(1):118-126. PubMed ID: 31027730
    [TBL] [Abstract][Full Text] [Related]  

  • 31. linc00968 inhibits the tumorigenesis and metastasis of lung adenocarcinoma via serving as a ceRNA against miR-9-5p and increasing CPEB3.
    Tang H; Han X; Feng Y; Hao Y
    Aging (Albany NY); 2020 Nov; 12(22):22582-22598. PubMed ID: 33159015
    [TBL] [Abstract][Full Text] [Related]  

  • 32. miR-31-5p modulates cell progression in lung adenocarcinoma through TNS1/p53 axis.
    Zhu C; Wang S; Zheng M; Chen Z; Wang G; Ma J; Zhang B; Huang W; Sun X; Wang C
    Strahlenther Onkol; 2022 Mar; 198(3):304-314. PubMed ID: 35037949
    [TBL] [Abstract][Full Text] [Related]  

  • 33. LncRNA GMDS-AS1 inhibits lung adenocarcinoma development by regulating miR-96-5p/CYLD signaling.
    Zhao M; Xin XF; Zhang JY; Dai W; Lv TF; Song Y
    Cancer Med; 2020 Feb; 9(3):1196-1208. PubMed ID: 31860169
    [TBL] [Abstract][Full Text] [Related]  

  • 34. SLCO4A1-AS1 promotes cell growth and induces resistance in lung adenocarcinoma by modulating miR-4701-5p/NFE2L1 axis to activate WNT pathway.
    Wei Y; Wei L; Li J; Ma Z; Zhang Q; Han Z; Li S
    Cancer Med; 2020 Oct; 9(19):7205-7217. PubMed ID: 32762035
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ginsenoside Rh2 attenuates the progression of non-small cell lung cancer by sponging miR-28-5p/STK4 axis and inactivating Wnt/β-catenin signaling.
    Ma J; Zhao D; Yu D; Song W; Yang X; Yin H
    Cancer Med; 2023 Jun; 12(11):12653-12667. PubMed ID: 37081781
    [TBL] [Abstract][Full Text] [Related]  

  • 36. miR-9-5p Promotes Lung Adenocarcinoma Cell Proliferation, Migration and Invasion by Targeting ID4.
    Zhu K; Lin J; Chen S; Xu Q
    Technol Cancer Res Treat; 2021; 20():15330338211048592. PubMed ID: 34723712
    [No Abstract]   [Full Text] [Related]  

  • 37. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis.
    Wang Y; Yang L; Chen T; Liu X; Guo Y; Zhu Q; Tong X; Yang W; Xu Q; Huang D; Tu K
    Mol Cancer; 2019 Feb; 18(1):28. PubMed ID: 30782188
    [TBL] [Abstract][Full Text] [Related]  

  • 38. LncRNA DGCR5 promotes lung adenocarcinoma (LUAD) progression via inhibiting hsa-mir-22-3p.
    Dong HX; Wang R; Jin XY; Zeng J; Pan J
    J Cell Physiol; 2018 May; 233(5):4126-4136. PubMed ID: 29030962
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MiR-449b-5p targets lncRNA PSMG3-AS1 to suppress cancer cell proliferation in lung adenocarcinoma.
    Yue N; Ye M; Zhang R; Guo Y
    BMC Pulm Med; 2020 May; 20(1):152. PubMed ID: 32471413
    [TBL] [Abstract][Full Text] [Related]  

  • 40. CircDUS2L (circ_0039908) promotes lung adenocarcinoma progression by upregulating PGAM1 by acting as a miR-590-5p molecular sponge.
    Tian Q; Guo Y; Liu J; Pang C; Wang Q; Xie Q; Li J
    J Biochem Mol Toxicol; 2023 Sep; 37(9):e23406. PubMed ID: 37392398
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.